← Leaderboards
Sheila Fleming
University Of Cincinnati
$2,091,076
Attributed
$2,091,076
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $334.8K · FY2011–24$500K$375K$250K$125K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,091,076 · 2
By mechanism
R01$1,659,326 · 1
R21$431,750 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Mission”
- Kelly K Wismer · Department Of Defense$358,750,224
- Mitchell J Malone · Texas A&M Research Foundation$353,400,900
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$333,898,233
- Michael E Cheney · Department Of Defense$330,315,072
- David Heimbrook · Leidos Biomedical Research, Inc.$325,587,550
- Gary D Acton · University Of California-Davis$320,373,312
Research focus
MissionParkinson DiseaseGenesLoss Of FunctionMutationPark9 GeneEarly OnsetFunctional DisorderInheritedLinkDisabilityMutantOverexpressionBehavioralBehavioral ImpairmentAlpha SynucleinAffectBrainAtp PhosphohydrolaseGeneticIn VivoKnockout MiceAccelerationPathologic
Grant awards (7)
ATP13A2 and Susceptibility to Neurodegeneration$329,485
R01 · FY2024 · ES · contact PI
ATP13A2 and Susceptibility to Neurodegeneration$329,485
R01 · FY2023 · ES · contact PI
ATP13A2 and Susceptibility to Neurodegeneration$330,822
R01 · FY2022 · ES · contact PI
ATP13A2 and Susceptibility to Neurodegeneration$334,767
R01 · FY2021 · ES · contact PI
ATP13A2 and Susceptibility to Neurodegeneration$334,767
R01 · FY2020 · ES · contact PI
The interaction between ATP13A2 and alpha-synuclein in mice$235,500
R21 · FY2012 · NS · contact PI
The interaction between ATP13A2 and alpha-synuclein in mice$196,250
R21 · FY2011 · NS · contact PI